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The Nodal signaling cascade is a signaling pathway that is conserved in 
vertebrates and is central to mesendoderm specification. Investigating the 
protein-protein interactions (PPIs) of this cascade is crucial to understanding 
development, disease and cancer. In this regard, the EGF-CFC family of proteins, 
of which the mouse Cripto is the founding member, has been the subject of 
previous investigations. However, in the absence of co-crystals, a clear picture of 
the domain-specific interactions of Cripto has remained elusive and hence, the 
precise geometry of the complex is unknown. This thesis addressed the above-
mentioned problem by creating a library of amber codon-directed, genetically 
encoded p-benzoylphenylalanine (Bpa) mutants of Cripto and utilizing it in 
crosslinking experiments to tease out individual direct, physical interactions of 
Cripto that occur in live cells by photocrosslinking. 
In utilizing the Bpa-mutagenesis method, we chose a HEK293 EBNA – pOriP 
vector platform which maximizes mutant protein production. We observed the 
use of a C-ter FLAG tagged Cripto in the literature to study its interactions and 
found this to be a peculiar choice since Cripto is a GPI anchored protein and 
tagging GPI anchored proteins at the C-ter might lead to ER rentention, thus 
minimizing the presence of Cripto in its native lipid raft plasma membrane 
location. Using a PI-PLC assay, we found that untagged Cripto is released into 
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the cell free supernatant while there was no evidence of C-terminally tagged 
Cripto-3FLAG being released into the cell-free supernatant. Nonetheless, we 
found that this C-ter tagged Cripto still retained ~60% of the activity of untagged 
Cripto in an A3-luc luciferase assay. Since plasma membrane complexes can 
form in the ER, we designed a Bpa-mutant study using the C-ter tagged Cripto to 
study its well-known interaction with the type I receptor, the human Alk4. A 20-
fold library of amber codon mutants was designed using site-directed 
mutagenesis. All 20 mutants were amenable to Bpa incorporation. UV 
crosslinking using genetically encoded Bpa was optimized in a proof-of-concept 
experiment using a Spectrolinker apparatus, which was found to be ~20 percent 
more efficient than a handheld UV lamp. UV crosslinking of all these 20 mutants 
yielded 2 prominent endogenous crosslinks at 75kD and 150kD but the identity 
of these interacting proteins is unknown. Cycloheximide chase assay revealed 
that these cross-links are not co-translational. The co-expression of Alk4-HA did 
not yield any additional crosslinks. 
To overcome the limitation of using a non-GPI anchored form Cripto in studying 
its native membrane interactions, we resorted to an N-ter FLAG-Cripto construct 
so as to not perturb GPI anchorage. This FLAG-Cripto was found to be released 
into the cell-free supernatant in a PI-PLC assay, indicating that it is GPI-
anchored. Using mutagenic PCR, 9 amber codon mutants were generated. 7 
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mutants were amenable to Bpa incorporation and Endo H assay revealed that all 
7 mutants carried sugar modifications. Activity of these Bpa mutants were 
analyzed using A3 luc assays but were inconclusive due to insufficient levels of 
mutant protein compared to levels of FLAG-Cripto which had significant 
activity. Cross-linking experiments yielded reproducible, endogenous cross-links 
and the precise identity of these interactors needs further investigation.  
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CHAPTER 1: INTRODUCTION 
1.1 Signaling pathways  
Signaling pathways are ubiquitous in the multicellular world and are central to 
understanding development and disease. In its simplest form, a signaling 
pathway is composed of a signaling molecule such as an extracellular ligand, a 
receptor (usually a membrane receiver) and intraceullar messengers or effectors 
that transmit the signal to the heart of the cell, the nucleus, to effect changes in 
specific gene expression (Jordan et al. 2000). In producing these changes, 
several proteins interact to form complexes and each complex is a cog in the 
signaling machine taking it one step closer to the signaling output. However, 
such a simple 3 component system is hardly sufficient to achieve the complexity 
of multicellularity and cells often employ multi-component signaling pathways. 
For instance the Nodal signaling cascade, a widely conserved pathway in 
vertebrates, has several components (Fig 1.1). This cascade consists of the TGF-
beta ligand, Nodal which signals through the Type I and Type II Activin 
receptors (Reissman et al. 2001, Ben-Haim et al. 2006). A co-receptor, which 
belongs to the EGF-CFC family of proteins, is known to have an obligate and 
specific role in Nodal signaling (Yan et al. 2002, Gritsmann et al. 1999). 
Activation of the Activin receptors by Nodal results in phosphorylation of the 
key transcription factor, Smad2 (Fei et al. 2010, Dubrulle et al. 2015). 
Phosphorylated Smad2 transmits the signal by assembling into heteromeric 
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complexes with other transcription factors such as Smad4, FoxH1 and Mixer and 
eliciting gene responses (Massague et al. 2005). Several protein-protein 
interactions (PPIs) may be envisioned on the cell surface in this pathway such as 
ligand-receptor, ligand-coreceptor, receptor-coreceptor, inhibitor-receptor, 






Figure 1.1: The TGFβ ligand Nodal signals through the Type I and Type II 
transmembrane Serine/ Threonine kinase receptors. Signal propogation requires 
the expression of the obligate co-receptor which belongs to the EGF-CFC family 
of proteins. Once the membrane receptors are activated, the Type I activin-like 
receptor phosphorylates a transcription factor Smad2. Phosphorylated Smad2, 
the intracellular messenger, oligomerizes with Smad4 and translocates to the 
nucleus to elicit the appropriate gene response. Signaling activity by Nodal can 
be attenuated by the expression of inhibitors such as Lefty and Cerberus. 
(Extracted from Schier and Shen 2002) 
 
1.2 The Nodal Signaling cascade in vertebrate development 
The Nodal signaling cascade is a widely conserved pathway in vertebrates that is 
central to mesendoderm induction and specification of left-right patterns (Conlon 
et al. 1994, Shen 2007, Schier 2009, Shiratori and Hamada 2014). The ligand, 
Nodal, was first identified from a retroviral insertional mutagnesis screen in 
mouse embryonic stem cells and resulted in an early gastrulation-defective 
phenotype (Robertson et al. 1986). Subsequently, the locus was mapped to a 
member of the transforming growth factor-beta (TGFβ) superfamily. Relatives of 
the mouse nodal were identified in genetic screens in zebrafish, which employs 
two redundant nodal ligands in squint and Cyclops that reiterate nodal function 
in mesendoderm formation (Feldman et al. 1998, Dougan et al. 2003, Hagos and 
Dougan 2007). Severe defects in mesendoderm such as a lack of notochord, 
pancreas, liver, heart, kidney and blood were observed in mutants of Nodal 
signaling in zebrafish (Gritsman et al. 1999). Mouse mutants demonstrated an 
absence of primitive streak, a tissue that is a source of mesendoderm progenitors 
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(Conlon et al. 1994). In the absence of Nodal signaling in the one-eyed pinhead 
mutant, cells which normally adopted a mesodermal fate such as the dorsal 
marginal cells switched to an ectodermal fate, giving rise to midbrain and 
hindbrain tissues (Carmany-Rampey and Schier 2001). Conversely, blocking the 
Nodal signaling inhibitor, Lefty, led to an enlarged pool of mesendodermal 
progenitors in zebrafish and mouse (Agathon et al. 2001 and Feldman et al. 
2002). Furthermore, ectopic Nodal signaling in ectoderm induced mesoderm and 
endodermal cell fates, underlining its role as a bona fide mesendoderm specifier 
(Schier and Shen 2000). Mechanistically, it has been shown in zebrafish and frog 
that a transcriptional restriction of Nodals at the blastula margin, a region that 
overlaps with the endoderm and is in close proximity to the presumptive 
mesoderm, is responsible for the spatial induction of mesendodermal fates 
(Schier and Talbot 2005). Nodal acts as a morphogen and the ability of different 
Nodal ligands to show different diffusivities, ranges of action, stability and 
regulation by the extracellular environment enables it to generate precise patterns 
(Huw Williams et al. 2004, Le Good et al. 2005, Schier 2009, Marjoram and 






Figure 1.2: (A) In frog, the VegT transcription factor activates the zygotic Xnr 
transcripts. Cortical rotation post-fertilization leads to an asymmetric 
translocation of Xnr transcripts and a stabilization of β-catenin on the future 
dorsal side resulting in dorso-ventral patterning. In zebrafish, activation of 
Cyclops and Squint (Nodal-related ligands) transcripts occurs at the blastoderm 
margin. Graded Nodal signaing (indicated by thick and thin lines) determines the 
animal-vegetal patterning. (Extracted from Shen 2007) 
 
Nodal signaling has role in left-right patterning which is triggered by the 
asymmetric expression of Nodal on the left side of the lateral plate mesoderm 
(Meno et al. 1999). Together with its inhibitor Lefty, Nodal establishes a self-
enhancement and lateral inhibition (SELI) system that is characterized by a 
combination of positive autoregulation, negative feedback loop and differential 
diffusivity (Hamada and Nakamura 2012). Consequently, the maintenance of 
high Nodal levels on the left-side of the lateral plate mesoderm results in an 
assymetric left-sided induction of the transcription factor, Pitx2, which is the 
14 
 
driving force behind the asymmetric morphogenesis of visceral organs such as 
heart, stomach and intestine (Shiratori et al. 2001, Yashiro et al. 2007).  
Additionally, Nodal signaling also plays a role in neural patterning although 
most neural tissue in animals is of ectodermal origin and requires that Nodal 
signaling be blocked, either through spatial restriction or generation of Nodal 
inhibitors (Thisse et al. 2000). However, in the zebrafish nervous system, the 
specification of ventral cell types requires Nodal signaling so much so that 
mutants of the Nodal gene, cyclops or the co-receptor, one-eyed pinhead lead to 
an absence of medial floor plate, ventral forebrain and cyclopia (Strahle et 
al .1997, Schier et al. 1997) . These defects are mirrored in vertebrate analyses 
of holoprosencephaly caused by mutations in the EGF-CFC gene, Cripto 
(McKean and Niswander 2012, Roessler and Muenke 2010). 
Peripheral roles of Nodal signaling include anterior-posterior axis patterning in 
mouse, maintenance of undifferentiated ES cells and in carcinogenesis. The 
absence of Nodal in mouse leads to an absence of Anterior Visceral Endoderm 
(AVE) and hence, a lack of an anterior-posterior axis (Norris et al. 2002). Cripto 
null mutation or hypomorphic alleles of Nodal do not lead to an absence of AVE 
but instead, the AVE fails to translocate to its prospective anterior side (Ding et 
al. 1998). Undifferentiated ES cells are characterized by high expression of 
Nodal pathway components (Brandenberger et al. 2004). Activation of the 
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Smad2/3 branch of transmitters in human ES cells by Nodal ligand is required to 
maintain markers of undifferentiated fate, Oct-4 and Nanog (James et al. 2005). 
Upregulation of Nodal pathway components is also observed in many human 
cancers. Increased Nodal expression in malignant melanoma and breast cancers 
showed a positive correlation with cancer progression (Topzcweska et al. 2006 
and Kirsammer et al. 2014). Upregulation of Cripto promotes tumorogenicity is 
xenografts and is linked to its ability to induce epithelial-mesenchymal 
transitions (Strizzi et al. 2004).  
1.3 EGF-CFC family of proteins in Nodal signaling 
The EGF-CFC family of genes encode extracellular growth factor-like or co-
receptor proteins. Human Cripto-1 (Teratocarcinoma-derieved growth factor-1), 
mouse Cripto-1 (Cr-1) and Cryptic, Xenopus FRL-1 and zebrafish one-eyed 
pinhead are members of this family of genes. Among the members of this family, 
sequence conservation is approximately 30% with no clear orthologous 
relationship (Saloman et al. 2000). However, functionally, the severe 
mesendodermal defects due to the loss of function of one member such as the 
zebrafish one-eyed pinhead can be rescued completely by mRNA injections of 
the mouse member, Cripto (Gritsman et al. 1999). Alternatively, different 
members within a species can also serve different roles in vertebrate 
development. For instance, the mouse Cripto induces mesendoderm and 
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positions the anterior-posterior axis while Cryptic is implicated in left-right axis 
determination (Ding et al. 1998 and Gaio et al. 1999). 
 
The EGF-CFC proteins consist of an amino-terminal signal peptide, an 
epidermal growth factor (EGF)-like domain, a cysteine- rich CFC domain and a 
hydrophobic C-terminus that contains a site for GPI-anchor attachment. The 
EGF-like domain contains six cysteines that can form three disulfide bonds and 
is capable of adopting a tertiary structure independently (Saloman et al. 2000). 
The EGF-like domain in EGF-CFC proteins are structural variants to canonical 
EGF ligands in that they are missing one of three signature loops of the EGF 
motif and consequently, EGF-CFC proteins offer no competition to the ErbB 
receptor ligands like EGF (Kannan et al. 1997). Post-translational modifications 
of EGF-CFC proteins include N-linked glycosylation and O-fucosylation 
(Saloman et al. 2000 and Shi et al. 2007). Although it is feasible that sugar 
modifications can affect the function of EGF-CFC proteins such as stability, 
diffusivity or even conformation, a clear link with any of these has not been 
established and in fact, O-fucosylation at Thr-72 has been shown not to have an 
effect on Nodal signaling in mammalian cell culture as assayed by an 
Activin/Nodal response element (A3) luciferase reporter (Shi et al. 2007). The 
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EGF-CFC proteins contain putative phosphorylation sites but this has not been 
the subject of any study to the best of our knowledge.  
 
Figure 1.3: Mouse Cripto is a 171 amino acid-long, GPI anchored protein. It 
contains an N-terminal signal peptide and a site for GPI anchorage predicted to 
be S145 (ω-site). Threonine-72 carries an O-fucose modification.  
 
In transfected mammalian cells, EGF-CFC proteins such as Cripto and oep 
localize to the cell surface via their GPI anchor-mediated localization to lipid 
rafts which fits with their role as a co-receptor in Nodal signaling (Minchiotti et 
al. 2000). However, injection of mRNAs such as the oepm134 into the yolk 
syncytial layer of zebrafish embryos , which encodes an oep protein lacking the 
last 16 amino acids, rescued MZoep mutants indicating that EGF-CFC proteins 
can act as diffusible ligands (Gritsman et al. 1999). A clear demonstration of 
soluble oep was however missing. In the same study, it was mentioned that 
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injection of full length oep mRNA into the yolk syncytial layer did not rescue 
MZoep mutants (data not shown), supporting a hypothesis wherein oep can act 
as a soluble ligand in zebrafish. Previous studies also established that in wild-
type embryos, oep is in its membrane-attached form and is essential in 
mesendoderm induction (Schier et al. 1997). Interestingly, the mesendodermal 
defects of MZoep were also rescued by injection of full length mouse Cripto and 
Xenopus FRL-1 mRNA, indicating the conserved function of EGF-CFC genes in 
germ layer specification (Gritsman et al. 1999). It can be generalized that EGF-
CFC proteins can act either as cell-autonomous receptor-like factors or as soluble 
non cell-autonomous ligands in vertebrates.  
The involvement of EGF-CFC proteins in Nodal signaling has been firmly 
established using mouse, zebrafish and frog genetics (Schier et al. 2000). At first 
glance, the similar phenotypes of MZoep and zebrafish Nodal-related are 
evidence that oep and the nodal-related genes, cyclops and squint, belong to the 
same pathway. Oep mutations can also block the gain-of-function phenotypes 
caused by nodal-related overexpression. Overexpression of oep alone does not 
alter the wild-type phenotype, also indicating that oep and Nodal-related act in 
concert. Interestingly, mRNA injections of Activin (another TGF-beta ligand) 
also rescued MZoep mutants, suggesting that Activin can offer a replacement for 
the concerted actions of oep and Nodal-related (Gritsman et al. 1999). Injections 
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of costitutively activated forms of the Type I activin receptor, ActRIB or the 
intracellular transmitter, Smad2 produce MZoep rescue effects too. Thus oep, 
Nodal-related, Activin receptors and Smad2 are all key components of the same 
pathway. In mouse, both Cripto and Nodal mutants also display severe 
mesendodermal defects but there exists an interesting discrepancy between the 
two. Nodal mutants display a lack of rostral neural structures, an effect absent in 
Cripto mutants (Varlet et al. 1997 and Ding et al. 1998). An involvement of the 
other EGF-CFC gene in mouse, Cryptic, may explain this discrepancy but is not 
supported by any experimental evidence so far. It is also entirely possible that 
Nodal signaling executes certain functions independently of Cripto (Schier and 
Shen 2000).  
1.4 INTERACTIONS OF EGF-CFC PROTEINS IN NODAL SIGNALING 
Considering the strong genetic evidence for the involvement of EGF-CFC 
proteins in Nodal signaling, two hypotheses were envisioned to explain their 
biochemical activity. In the first hypothesis, EGF-CFC proteins could directly 
bind Nodal ligands and subsequently assemble into functional complexes with 
the Activin receptors. Alternatively, EGF-CFC proteins may merely be 
facilitators in Nodal signaling by inducing conformational changes either in the 
ligand or activin receptors (Schier and Shen et al. 2000). Subsequent studies by 
several independent groups offer strong evidence for the direct binding role of 
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EGF-CFC proteins. The second hypothesis has received no attention to the best 
of our knowledge and hence, cannot be ruled out entirely. We review the 
approaches and their results below. 
The earliest study on the interactions of EGF-CFC proteins relied on injections 
of mouse Cripto-FLAG mRNAs into Xenopus embryos along with other putative 
interacting components of the pathway such as Nodal and the human Activin 
Type I receptor, Alk4 (Whitman and Yeo 2001). Cripto was found to 
biochemically interact with Alk4 and this interaction did not depend on the 
ectopic presence or absence of the ligand. This interaction was also specific since 
Cripto failed to immunoprecipitate with the BMP Type I receptors, Alk2 and 
Alk3. Double point mutants of Cripto such as N69G and T72A (Cripto mEGF1), 
R88G and Q91G (Cripto mEGF2) or even EGF domain deletion failed to abolish 
this interaction and also did not induce Smad2 phosphorylation. However, a 
H104G and W107G (Cripto mCFC) double mutant abolished this interaction, 
providing evidence for the CFC domain’s role in binding Alk4. Deletion of the 
EGF-domain on the other hand, abolished a biochemical interaction with the 
Nodal ligand. Interestingly, composite mutants which combined any of the above 
EGF domain double mutants with Cripto mCFC or the mCFC mutant alone still 
elicited low levels of Smad-2 phosphorylation in Xenopus embryos, indicating 
that Nodal function can exist without a non-Alk4 binding Cripto but cannot exist 
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without an intact EGF domain. Nonetheless, it was found that a kinase defective 
Alk4 immunoprecipitates Nodal only when a full-length Cripto-FLAG was used 
and not when an EGF-deleted derivative was used, supporting evidence for a 
Cripto-Alk4 co-receptor relationship. Further evidence for EGF-domain binding 
to Nodal and CFC-domain binding to Alk4 emerged from NCCIT cell line 
activity readouts upon exposure of Nodal signaling cells to a panel of Cripto 
monoclonal antibodies (Adkins et al. 2003). Anti-EGF domain monoclonal 
antibodies had a more severe effect on Nodal signaling than anti-CFC domain 
monoclonal antibodies, although variation between the relative affinities of both 
antibodies to their respective epitopes cannot be ruled out. However, the use of 
an untagged EGF-domain deleted Cripto was shown to biochemically interact 
with Nodal in a HEK293 overexpression system (Blanchet et al. 2008). Several 
different versions of Nodal such as the proprotein, the mature ligand, the 
hyperglycosylated variant independently immunoprecipitated with untagged 
Cripto which is in disagreement with work from the Xenopus system by Yeo and 
Whitman (2001). Moreover, it was shown using immunofluorescence 
experiments that Cripto plays a role in localizing Nodal to endosomes and 
deletion of the EGF domain led to an absence of membrane localization. 
Furthermore, using a Xenopus embryo expresiion system and a Cripto-FLAG 
mRNA, DTSSP crosslinking also revealed a biochemical interaction between 
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zebrafish Lefty1, the inhibitor of Nodal signaling and Cripto-FLAG. 
Recombinant, purified Lefty and Cripto were also crosslinked using DTSSP 
(Cheng et al. 2004). Whether Lefty binds the EGF domain like the ligand Nodal 
is unknown, but likely given the competitive nature of the two ligands. It is 
unclear whether the Cripto-FLAG proteins expressed in the above experiments 
are membrane-anchored, soluble or even trapped intracellularly due to defects in 
GPI anchor processing (Watanabe et al. 2007). Tagging Cripto at the C-terminus 
with a V5His tag retained less than 50 precent of the activity of an untagged 
wild-type in n2(7)-luc reporter assays (Watanabe et al. 2007) In general, GPI-
anchored proteins are cleaved at the C-terminus by a GPI-protein transamidase 
and tagging Cripto at the C-terminus would lead to cleaving of the tag along with 
the hydrophobic region that follows the GPI-anchoring site (Fig. 1.4) 
(Hamberger et al. 1995, Sutterlin et al .1997, Mayor and Riezman 2004, 
Hancock 2004). In this regard, the appearance of full-length Cripto-FLAG in 
their anti-FLAG Western blotting analyses is peculiar (Minchiotti et al. 2001). It 
is possible that these full-length Cripto-FLAG proteins are in an intracellular 
non-GPI anchored state and might still form complexes with the membrane 





Figure 1.4: GPI-anchored proteins are synthesized as precursors with an amino-
terminal signal peptide, whose cleavage by a signal peptidase targets the protein 
to the lumen of the ER. The GPI-attachment site (ω-site) is typically separated 
from a hydrophobic region (GPI signal sequence) by a hydrophilic spacer region. 
Crucially, the carboxy-tail is cleaved at the peptide bond at the GPI-attachment 
site and the carboxy-tail is released. (Extracted from Mayor and Riezmann 2004)  
 
In another study, an N-terminally FLAG-tagged version of Cripto which 
preserves the sequence around the GPI anchoring region in the C-terminus was 
utilized to investigate the interactions of Cripto in mammalian cell culture by the 
membrane-impermeable crosslinker, DTSSP (Yan et al. 2002). Nodal failed to 
immunoprecipitate triple mutants of the EGF domain, L75A/S77/F78 and 
P82A/F85A/R88A while triple mutants of the CFC domain displayed a weak 
interaction to Nodal compared to the wild type, a result consistent with their A3 
luc reporter assays. These results implicated a role for the EGF domain in Nodal 
binding. However, the two CFC domain triple mutants, H104A/W107A/R116A 
and L122A/P126A/ D134A retained the ability to interact with human ActRIB 
contradicting the earlier study which utilized the Xenopus system. It is unclear 
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whether substitution to alanine as opposed glycine (in the Xenopus study) 
accounts for this difference.  
Minchiotti et al. (2001) designed an MZoep phenotypic rescue assay by injecting 
mutants of Cripto mRNA to arrive at sites that have a functional relevance. By 
assaying a library of 15 point mutants and 2 deletion mutants and comparing 
rescue efficiency to the wild type Cripto mRNA, 10 point mutations with a 
functional defective phenotype and 2 loss-of-function mutations were identified 
(Table 1). First, the ability of Cripto to function as a soluble ligand was 
established by rescuing MZoep mutants with purified recombinant Cripto-His 
protein injections into the extracellular space at blastoderm stage. Even a 
trimmed, recombinant Cripto-His missing the N-terminus preceding the EGF 
domain and also the C-terminal hydrophobic domain demonstrated an ability to 
rescue MZoep, indicating that intact EGF and CFC domains are sufficient for 
activity. However, a Q91A point mutation was sufficient to abolish this rescue 
effect even when injected at relatively high amounts, revealing a site essential to 
the functional preservation of Nodal signaling. Interestingly, the artificial 
dimzerization of Cripto through the generation of a Cripto containing an Fc 
domain was as active as the Cripto-His protein in the rescue assay. Thus, it is 
possible that Cripto can act as a dimeric soluble ligand in Nodal signaling, 
although evidence for the in vivo existence of such a form is absent in the 
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literature. To tease out individual sites that may have a functional relevance to 
biological activity, mutant Cripto mRNAs were injected to assay for MZoep 
rescue. Subsequently, a Cripto model generated by superimposition onto a 
homologue, FGF, was investigated to elucidate the structural context of these 
point mutations (Fig 1.4). Importantly, sites G71 and F78 were identified to be 
absolutely critical for activity and fully exposed, hinting at a possible Nodal 
interaction role. Most of the mutations affecting activity were also found to be on 
the same side with an exposed area of 800-1000 A2, an area large enough for 
interactions with several proteins. These results fit well with homology models 
of human Cripto-Nodal interaction (Calvanese et al. 2010). In human Cripto, 
sites G87, T88 and F94 (equivalent to mouse G71, T72 and F78) were found to 
be fundamental for Nodal interaction. Moreover, solution structures of the mouse 
Cripto CFC domain mutant W107A display an altered conformation where the 
H104 and A107 residues are solvent-exposed but not iso-oriented as opposed to 
the wild type where these two residues are both solvent-exposed and iso-oriented 




Table 1: mRNAs for Cripto encoding the desginated alanine substitutions were 
injected into MZoep zebrafish embryos. Grades of rescue were determined as 





Figure 1.5: Space-filling model of mouse Cripto highlighting the mutated 
residues. Sites in red are ineffective and mutations do not affect rescue of MZoep 
fish. Mutations of residues in blue and cyan had a severe and less severe effect 
on phenotypic rescue respectively. Green arrows refer to β-strands while loops 
are indicated as yellow ropes. (Extracted from Minchiotti et al. 2001)  
 
Although Cripto’s interactions in Nodal signaling has been the subject of several 
studies, an unusual role in Activin signaling was shown by Gray et al. (2003). 
Activin, another TGF-beta ligand signals through the Type I and Type II Activin 
receptors bypassing the requirement of EGF-CFC co-receptors (Massague 1998). 
HepG2 cells displayed a 4-fold attenuation of Activin-A signaling as assayed by 
the 3TP-lux reporter when Cripto-FLAG was expressed in the system (Gray et al. 
2003). Deletion of the EGF-domain relieved this attenuation, adding weight to 
the argument that the EGF domain is the ligand binding domain. Crosslinking 
experiments using disuccinimidyl suberate revealed that Cripto prevents activin 
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crosslinking to its receptor, ActRIB, providing evidence for a dead, trimolecular 
Cripto-ActRIIB-Activin-A complex, although no evidence for a Cripto-Act-A 
interaction was observed. This attenuation effect on Activin-A was not 
reproduced by Adkins et al. (2003) although an antagonism of Activin-B 
signaling was observed through an NCCIT cell growth inhibitory assay. 
Moreover, a direct interaction between Activin-B and Cripto was inferred 
through Surface Plasmon Resonance. A mechanism of how Cripto attenuates 
Activin signaling is largely unclear and several models have been proposed 
(Shen 2003)(Fig. 5) 
 
 
Figure 1.6: (a) and (b) Activin and Nodal differ in that Activin does not need the 
presence of an EGF-CFC protein like Cripto to activate the signaling cascade as 
apposed to Nodal. However, Cripto expression can attenuate activin signaling by 
model (c) where Cripto binds activin in the presence of the Type II activin 
receptor ActRIIB. Alternative models of attenuation include d-f where Cripto 
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could sequester the Type I receptor, ActRIB and hinder the activin-ActRIB 
interaction (d and e) or directly interact with activin (f). (Extracted from Shen 
2003) 
 
1.5 INVESTIGATING PROTEIN-PROTEIN INTERACTIONS USING 
GENETICALLY ENCODED p-BENZOYLPHENYLALANINE 
The use of unnatural amino acids to add new functionalities to proteins has been 
an area of considerable interest for several years (Nowak et al. 1998, Dougherty 
et al. 2000, Liu et al. 2007, Wang et al. 2007, Neumann et al. 2010, Wang et al. 
2014 and Kim et al. 2013). The prospect of modifying proteins to confer 
properties which none of the natural 20 amino acids possess such as fluorescence, 
crosslinking, metal-ion binding has the potential to uncover novel information 
about proteins in their native environment. While earlier approaches relied on 
chemically aminoacylating tRNAs with unnatural amino acids, the yield of 
recombinant protein was low since the tRNAs could not be reacylated. More 
recently, a synthetic biology approach that incorporates genetically encoded 
unnatural amino acids via an orthogonal pair of tRNA-aminoacyl tRNA 
synthetase (Fig. 5a and 5b) has been established in E.coli, S. cerevisiae, S. pombe, 
mammalian cells, D. melanogaster and C.elegans (Chin et al. 2002, Wang et al. 
2010, Liu et al. 2007, Hancock et al. 2010, Chen et al. 2009, Nan et al. 2015, 






Figure 1.7: The genetic code is expanded by creating a unique codon for the 
incorporation of unnatural amino acids, namely the TAG codon. Since 
endogenous aminoacyl tRNA-synthetases and tRNAs can only introduce the 20 
natural amino acids into proteins, orthogonal synthtase-tRNA pairs which have 
been evolved artificially to have a selective recognition for unnatural amino 
acids are introduced into the translation system. The orthogonal pair is always 
borrowed from a species that is divergent enough from the species where 
recombinant protein synthesis is intended to avoid misacylation of the 
endogenous tRNAs by the orthogonal synthetase or misacylation of the 
orthogonal tRNAs by endogenous synthetases. (Extracted from Schultz and 






Figure 1.8: Active-site of the aminoacyl tRNA-synthetase, TyrRS has been 
artificially evolved for selective recognition of the unnatural amino acid. The 
tRNA that is charged with Tyr has been evolved for recognition by the evolved 
TyrRS and for incorporation of the unnatural amino acid at the TAG codon only. 
(Extracted from Sakamoto lab page) 
The strategy of site –specific incorporation of p-benzoylphenylalanine (Bpa) 
using orthogonal pairs has been established in E.coli, S.cerevisiae and 
mammalian cells (Chin et al. 2002, Chin et al. 2003, Hino et al. 2006). This 
unnatural amino acid has a short crosslinking distance and reacts with nearby –
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CH bonds upon excitation at 350-365nm (Sato et al. 2010, Hino et al. 2005). The 
crosslink is covalent and hence has the potential to uncover weak and transient 
interactions that a coimmunoprecipitation might fail to identify (Hino et al. 
2005). Since incorporation is site-specific, this strategy also uncovers mapping 
data about the interaction. Most importantly, the photocrosslinking approach can 
be applied to live cells prior to cell lysis and hence can reflect native protein 
interactions that occur in the cellular milieu (Hino et al. 2005). 
The first demonstration for genetically encoded Bpa crosslinking came from 
crosslinked GST dimers in an E.coli platform. Based on Crystal structures, 
replacement of F52 with Bpa and subsequent UV excitation yielded covalently 
crosslinked dimers while substitution at Y198, a site which lies outside the 
dimeric interface did not yield a crosslinked adduct (Chin et al. 2002). This 
proximity effect is crucial since the probability of trapping non-specific partners 
is minimal. This has made it possible to uncover specific protein interactions in a 
large multimeric complex like yeast translation initiation complexes using Bpa 
mutants of the TATA binding protein (Mohibullah and Hahn 2008). 
Multifunctional aspects and domain-specific crosslinks of a single protein such 
as the yeast mitochondrial translocator, Tom22, were revealed by using a large 
library of Bpa mutants (Shiota et al. 2011). In mammalian cells, Bpa 
crosslinking has been shown to validate structural data of the Grb2-EGFR, 
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CRLR-RAMP2 complex, CD38 multimers and IL5RA-IL5 interactions (Hino et 
al. 2005, Kusano et al. 2011, Yokoyama et al. 2012, Kusano et al. 2012). In the 
absence of structural data, prior scanning mutagenesis or molecular modeling 
studies may be relied upon to design a Bpa library as was demonstrated for the 
Neurokinin-1 receptor-Substance P and GPCR-maraviroc interactions (Valentin-
Hansen et al. 2014, Grunbeck et al. 2012). Moreover, Bpa-crosslinked crystal of 
gankyrin-Bpa-S6C showed minimal structural perturbation and preserved the 
native binding mode of protein (Sato et al. 2010). Additionally, Bpa cross-
linking has also been used as an optical switch to photoinactivate glutamate 
receptors in vivo rapidly (Klippenstein et al. 2014)  All of these above-mentioned 
studies gave us the confidence that genetically encoded Bpa crosslinking is an 












CHAPTER 2: OBJECTIVES OF THIS THESIS 
The Nodal pathway is a widely conserved signaling cascade in vertebrates that is 
central to mesendoderm induction and left-right patterning (Schier and Shen 
2007). Defects in Nodal signaling can cause severe defects in humans such as 
holoprosencephaly (Gripp et al. 2000). Recently, Nodal signaling has also been 
shown to play an active role in tumorigenesis and cancers (Topzcweska et al. 
2006, Kirsammer et al. 2014). Understanding the how proteins are organized and 
interact in this pathway is key to elucidating mechanisms of development and 
disease states. At the heart of this pathway is the EGF-CFC family of proteins of 
which the mouse member, Cripto, has been the subject of several investigations 
(Yeo and Whitman 2001, Minchiotti et al. 2000, Gray et al. 2003). A general 
consensus is that Cripto is a co-receptor in the Nodal pathway and can associate 
with Nodal and the Activin receptors (Yeo and Whitman 2001, Schier and Shen 
2000). In vivo, Cripto also demonstrates activity as a soluble ligand (Gritsmann 
et al. 1999, Minchiotti et al. 2001). 
Our review of the Cripto interaction problem and the experimental approaches 
used therein unearthed a few open questions. First, role of the EGF domain is 
unclear and different experimental systems and notably, use of tagged or 
untagged versions of Cripto constructs yielded contradicting results. While Yeo 
and Whitman’s work (2001) revealed that EGF domain interacts with Nodal and 
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the CFC domain with Alk4, Blanchet et al. (2008) show that this is not the case. 
In the latter’s work, deleting the EGF domain did not lead to an abolishement of 
Nodal-Cripto interaction. Two notable differences in their experimental 
approaches are the heterologous expression system used (Xenopus embryos and 
DTSSP crosslinking versus cell lines and coimmunoprecipitation) and the Cripto 
constructs. Several groups have used the C-terminally FLAG tagged version of 
Cripto while Minchiotti’s work used an untagged version. Cripto is a GPI-
anchored protein and the synthesis of the anchored-form necessitates that the C-
terminus beyond the GPI anchor site, the ω site, is cleaved off (Mayor and 
Reizman 2004). Thus, it is unclear how the addition of a C-terminal FLAG tag 
beyond the final amino acid of Cripto can lead to the presence of a full-length, 
GPI- anchored Cripto-FLAG in their anti-FLAG western analyses. Cripto’s role 
as an attenuator of Activin signaling is another interesting problem due to its 
relevance to several human cancers (Saloman et al. 2000). Cripto is 
overexpressed in breast, pancreatic, ovarian and colon cancers and hence, the use 
of anti-Cripto antibody blockade as a therapeutic tool has been proposed by 
Adkins et al. 2003. A heteromeric Cripto-Act-A-ActRIIB “dead” complex was 
proposed by Gray et al. (2003) but a direct interaction between Cripto and Act-A 
was not detected. In contrast, these results were not reproducible by Adkins et al. 
(2003) although an antagonism of Activin-B signaling was interpreted from 
NCCIT cell growth assays. SPR revealed a direct interaction between Cripto and 
36 
 
Activin-B and unexpectedly, the interaction was mapped to the CFC domain 
using a panel of anti-CFC domain antibodies. Thus, whether the two TGF-beta 
ligands, Activin and Nodal, bind to different sites on Cripto is uncertain and 
needs a rigorous approach. 
The main objective of this thesis is to ask what are the direct, physical 
interactions of Cripto in Nodal signaling in live cells. While 
immunoprecipitation is most commonly used to investigate interactions, its 
indirect and non-physiological nature are drawbacks. Immunoprecipitation of a 
single component of a multimeric signaling complex like Nodal signaling leads 
to precipitation of all components and teasing out the precise geometry of the 
complex is not possible. Chemical crosslinkers such as DTSSP can also yield 
non-specific crosslinks due to their long spacer arm. Also, their reactivity toward 
interacting proteins is selective only for the amino group and hence a preference 
for lysine and arginine is to be expected. Moreover, the crosslinker is cleaved in 
a denaturing SDS-PAGE and hence, interpreting a direct interaction with utmost 
confidence is problematic. 
In order to address the above shortcomings, we will adopt the synthetic biology 
approach of genetically encoding a site-specific photocrosslinking amino acid, p-
benzoylphenylalanine (Bpa). The advantages of this approach over the previous 
ones are that it can be applied to live mammalian cells such as HEK293 c-18, is 
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site-specific, short-range and more stringent, and the non-cleavable nature of the 
Bpa crosslinker in a denaturing SDS-PAGE. Although we found less than 10 
studies of genetically encoded Bpa crosslinking in mammalian cell platforms in 
the literature, the above-mentioned advantages and the importance of the Cripto 
problem has the potential to yield valuable insight into how Cripto works. Cripto 
is also a short protein of 171 amino acids with prior mutagenesis and molecular 
modeling data, permitting the generation of a rationally-designed Bpa mutant 
library which could provide the necessary sub-domain-specific resolution of its 
interactions.  
The experimental aims of this thesis are as follows: 
1. Considering the contrasting results of using different epitope tagging 
strategies on Cripto, we aim to assess the activity and localization (GPI-
anchored/soluble/neither) through simple A3 luciferase assays and PI-
PLC treatment assays. 
2. Based on the above, we aim to create an amber mutant library on the 
appropriate parent Cripto construct and analyze the incorporation of Bpa 
into these mutants using biochemistry. 
3. Utilize the Bpa mutant library in crosslinking experiments and analyze 




CHAPTER 3: MATERIALS AND METHODS 
3.1 Cripto wild-type & TAG mutant plasmids: 
The pCS2 Cripto-3FLAG vector was a gift from Dr. Karuna Sampath (Warwick 
Medical School) and has been described in Yeo and Whitman (2001). The 
Cripto-3FLAG insert was transferred from the pCS2 background to an oriP 
vector using in-fusion cloning with primers in Table 2. To generate the untagged 
version, two TAA stops were inserted in-frame before the 3x FLAG tag by a 
mutagenic, inverse PCR. To generate the N-terminally 1xFLAG-tagged version, 
the plasmid containing the untagged version was subjected to a mutagenic, 
inverse PCR using primers to insert a FLAG tag after the first 17 amino acids. 
To generate TAG codon mutants, the poriP-Cripto-3FLAG or the poriP-FLAG-
Cripto were chosen as templates. Mutagenic primers for these inverse PCRs are 
listed in table 2 and in all cases, Kapa Hifi (from Kapa Biosystems) was used. 
Kapa Hifi’s manufacturer instructions were chosen as PCR conditions and the 
number of cycles was 20 for a 25ul reaction. 4.5ul of the reaction were subjected 
to bacterial transformations by heat shock and colonies were screened for the 
mutation by sequencing.  
3.2 Other plasmids: 
The pCS2 Alk4 (K/R)-HA and pCS2 Nodal-FLAG was a gift from Dr. Karuna 
Sampath. Activin-A (R&D systems), and the pARE-luc reporter (describe in 
Wrana et al. 1992) was a gift from by Dr. Ray Dunn (IMCB). The psupT-BpaRS 
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orthogonal pair vector, poriP-GST-FLAG and poriP-GST(Am52)-FLAG were 
gifted by Dr. Kensaku Sakamoto (RIKEN-SSBC).  
3.3 Cell line & transfections: 
HEK293 c-18 stably expressing EBNA was purchased from ATCC. The cells 
were grown and split at ratios ranging from 1:2 to 1:5 in DMEM containing 10% 
FBS unless otherwise stated. For luciferase assays in 24-well plates, cells were 
tranfected at 90 percent confluence with 0.2ug Cripto, 0.2ug Nodal, 0.25ug 
pARE-luc, 0.1ug Fast 2, 0.025ug Renilla reporter. In control experiments, 
pcDNA was transfected to equalize the amount of DNA transfected. For co-
culture luciferase assays, 8ug of Nodal was transfected in a 100mm dish and a 
second 100mm dish was transfected with FLAG-Cripto (0.5/1.0/1.5/2.0 ug) or 
4ug FLAG-Cripto(Am) mutant, 4ug psupT-BpaRS, 2.5ug pARE-luc, 1ug Fast2 
and 0.250ug Renilla reporter. PcDNA was added to equalize the amounts of 
DNA transfected. For incorporation of Bpa, 4ug of the Cripto(Am) construct was 
transfected along with 4ug of psupT-BpaRS. For cross-linking experiments with 
Alk4-HA, 2ug of pAlk4 (K/R)-HA was mixed with 4ug of the Cripto(Am) 
construct and 4ug of psupT-BpaRS. For all transfections, Lipofectamine 2000 
(Invitrogen) was used according to the manufacturer's instructions at a 




3.4 Incorporation of Bpa & photocross-linking:  
Cells in 100mm dishes were transfected at 90 percent confluence with the 
constructs indicated above. Four hours post-transfection, the growth medium 
was replaced with DMEM containing 1mM Bpa (Bachem) and cells were lysed 
36 hours later for biochemistry. For preparation of Bpa-containing DMEM, the 
required amount of Bpa was dissolved in 1M hydrochloric acid until it becomes 
a clear, colorless solution. The Bpa solution was then added to 12.5ml of DMEM, 
followed by neutralization with 1M sodium hydroxide to restore the pink color 
of DMEM. The medium was then filtered through a 0.22 micron filter. 
 For cross-linking, live cells on ice were exposed to the UV handheld lamp or the 
Spectrolinker XL-1500 (Spectronics Corp.) for the indicated duration. The 
distance between the UV source and the cell culture dish was never more than 
5cms. Post-cross-linking, cells were rinsed with PBS and lysed for biochemistry.  
3.5 Cell lysis, immunoprecipitation and western blotting: 
Cells were lysed in 400ul lysis buffer containing 50mM Tris pH7.4, 150mM 
NaCl, 0.1% Triton X-100, 25mM EDTA and protease inhibitor tablets (Roche) 
on ice for 30 minutes. The lysate was scraped using cell scrapers (Corning) and 
centrifuged at 13000rpm for 10 minutes. For FLAG immunoprecipitations, 20ul 
of FLAG magnetic beads (Sigma) was added to the lysate and mixed on a 
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nutator at 4C for 2 hours. The beads were washed 5 times with lysis buffer and 
subjected to peptide elution using 1x FLAG peptide or 3xFLAG peptide (Sigma). 
The eluent was mixed with SDS loading buffer and subjected to electrophoresis 
in 4-20% gradient precast gels (Biorad). The proteins were transferred to PVDF 
membranes at 100V for 1 hour using a wet transfer apparatus (Biorad). 
Membranes were blocked on a shaker in 5% non-fat dry milk (2.5g in 50ml of 
TBS containing 0.1% Tween-20) for 1 hour at room temparature and probed 
with the indicated antibody at 4C overnight. The antibodies used were mouse 
anti-FLAG M2 (Wako), rabbit anti-Cripto (Cell Signaling) or rat anti-HA 
(Roche) or a HRP-conjugated FLAG antibody (Sigma). The primary antibodies 
were diluted appropriately in TBS-T (0.1% Tween-20) containing 1% non-fat 
dry milk. The membranes were washed 5 times with TBS-T (0.1% Tween-20) 
for 10 minutes each. After washing, the membranes were incubated with anti-
mouse or anti-rabbit HRP-conjugated secondary antibodies (Abcam) for 1 hour 
at room temperature on a shaker. The secondary antibody was washed with TBS-
T (0.1% Tween-20) 5 times, 10 minutes per wash. The chemiluminescence 
detection was carried out using the ECL Prime Reagent and Amersham 





3.6 Luciferase assays: 
Cells were transfected with the DNA mixes mentioned previously. Four hours 
post-transfection, the media containing serum was replaced with serum-free 
DMEM. 36 hours later, cells were suspended in a small volume (75ul) of 
DMEM in 96 well plates. Dual Glo Luciferase Assay System (Promega) was 
performed according to the manufacturer’s protocol and activity was measured 
in Microplate Reader (Tecan).  
3.7 Endo H assays: 
The FLAG-tagged Cripto was immunoprecipitated and eluted using FLAG 
peptide. The eluent was denatured, mixed with Endo H (NEB) and incubated at 
37C for 2 hours. Post-treatment, the eluents were boiled in SDS loading dye and 
processed for western blotting. 
3.8 PI-PLC assays: 
Cells were suspended in PBS 24 hours post-transfection in 24 well plates and 
treated with 1U/ml PI-PLC (Sigma) for 30 minutes at 37C. Post-treatment, cells 
were centrifuged at 1000rpm. Both the supernatant and the cell lysates were 




3.9 Cycloheximide chase assay: 
Cells were incubated with cycloheximide (50ug/ml) for the indicated duration, 
36 hours post-transfection. Cells were then cross-linked in a Spectrolinker and 
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CHAPTER 4: RESULTS 
4.1 A proof of concept Bpa crosslinking experiment 
We first wanted to establish the method to site-specifically incorporate Bpa into 
proteins and use the Bpa containing protein to cross-link with its interactor in our 
hands. For this, we adopted a proof-of-concept experiment of GST-dimerization 
which was established in E.coli based on the structure of the GST dimer (Chin et 
al. 2002).Briefly, the incorporation of Bpa at the dimeric site ( F52) and UV 
excitation by 365nm light would result in the formation of covalently cross-
linked GST dimers which migrate unresolved in a reducing SDS-PAGE. We 
successfully established this result in our HEK293 c-18 platform. Full-length 
GST-FLAG expression was observed only upon the addition of Bpa to the 
medium and absence of Bpa did not yield this product (Fig 4.1, lanes 5 and 3 
respectively), indicating that the psupT-orthogonal pair is specific for Bpa 
incorporation. Additionally, we observed the formation of a cross-linked GST 
dimeric product only upon exposure to 365nm UV light (Fig 4.1, lane 4). UV 
excitation of the wild-type GST-FLAG did not yield any cross-links, indicating 
that in the context of GST, cross-linking into dimers can only be established 
through the introduction of Bpa and not through any of the natural amino acids. 
Thus, Bpa was found to be site-specifically incorporated and a reliable 




Figure 4.1: HEK293 c-18 cells were transfected with the constructs indicated 
above the lanes. The serum-containing media was replaced with DMEM or 
DMEM containing Bpa as indicated by – or + . 36 hours post-transfection, cells 
were exposed or un-exposed to a 365nm handheld UV lamp for 30mins on ice as 
indicated by a + or - . Cells were lysed, immunoprecipitated and the GST-FLAG 
was eluted by FLAG peptide. Expression was analyzed in an anti-GST Western 
blot. 
 
4.2 Cripto-3FLAG is not the GPI-anchored version of Cripto 
Our literature review revealed at least 4 independent studies (introduced 
previously) which used Cripto with a 3xFLAG epitope tag at the C-terminus 
(Yeo and Whitman 2001, Minchiotti et al. 2001, Gray et al. 2003, Cheng et al. 
2004). These studies did not ascertain the localization of Cripto-3xFLAG 
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although a full-length protein was observed in their anti-FLAG western blots. 
Upon careful consideration of the normal GPI-anchoring process (reviewed in 
Mayor and Riezman, 2004), we argue that the full-length Cripto-3FLAG 




Figure 4.2: Schematic showing the removal of C-terminal tags during the GPI-
anchoring process in the ER. 
 
To analyze whether Cripto-3FLAG expressed in HEK293 c-18 cells is in the 
GPI-anchored form, we performed a PI-PLC assay with cells expressing 
untagged Cripto and Cripto-3FLAG to examine evidence for their release into 
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the cell-free supernatant. PI-PLC is an enzyme that is used in the release of GPI-
anchored proteins from the membrane. The treatment of cells expressing 
untagged Cripto led to the release of the protein into the cell-free supernatant 
while untreated cells did not (Fig. 4.2(top panel), lanes 2 and 4). However, PI-
PLC treatment did not lead to the release of Cripto-3xFLAG into the cell-free 
supernatant (Fig. 4.3(bottom panel), lane 4) as shown by an anti-FLAG Western 
blot. Thus, while untagged Cripto is GPI-anchored and can be released into the 
cell-free supernatant, there is a clear lack of evidence for the GPI-anchorage 






Figure 4.3: Cells expressing untagged Cripto (top panel) or Cripto-3xFLAG 
(bottom panel) were treated with PI-PLC or not (as indicated). Post-treatment, 
cell lysates (P) and cell-free supernatants (S) were subjected to Western Blotting 
with the appropriate antibody. 
 
4.3 Activity of Cripto-3xFLAG 
We speculated that these Cripto-3xFLAGs are trapped in the ER due to their 
GPI-unanchored state and hence can still form complexes with the 
transmembrane protein, the human Alk4. Previous studies also indicated a 
biochemical interaction between Cripto-3xFLAG and Alk4. So, we retained the 
Cripto-3xFLAG construct as a template to design a library of unnatural amino 
acid mutants to investigate its interaction with Alk4. But first, we wanted to 
ascertain if Cripto-3xFLAG was active in Nodal signaling. To examine the 
signaling activity of Cripto-3xFLAG, we employed the pARE-luc reporter assay 
which has been used in several studies as a reporter of Nodal signaling output 
(Yan et al. 2002, Watanabe et al. 2007). We found that in agreement with 
Watanabe et al, 2007, Cripto3xFLAG expressing cells retain a reduced level of 






Figure 4.4: ARE-luciferase assay of HEK293 c-18 cells transfected with Cripto-
3xFLAG or untagged Cripto or pcDNA with Nodal, Fast2, ARE-luc reporter and 
a Renilla reporter. Cells were lysed and subjected to a luciferase assay 24 hours 
post-transfection. Experiments were carried out in technical triplicates. 
 
4.4 Cripto-FLAG library containing site-specifically incorporated Bpa 
We then designed a 20-fold library of TAG codon mutants of Cripto-3xFLAG as 
the first step towards unnatural amino acid mutagenesis with p-
benzoylphenylalanine (Bpa). The sites chosen for TAG codon mutagenesis and 
the rationale for their choice are listed in Table 3. The sites can be categorized as 
Nodal-interacting, Alk4-interacting or randomly chosen. 
Amino acid mutated  Rationale for 
mutagenesis 
Nature of previous 
evidence 
L62 Random N/A 




G76 Proximity to NIS N/A 
S77 Proximity to NIS N/A 
F78 NIS, solvent exposed Oep rescue assay, 
homology model 
A80 Proximity to NIS N/A 
S84 Random N/A 
G87 Proximity to NIS N/A 
K96 Random N/A 
G100 Proximity to AIS N/A 
S101 Proximity to AIS N/A 




G105 Proximity to AIS N/A 
T106 Proximity to AIS N/A 






K110 Proximity to AIS N/A 
L114 Random N/A 
G120 Random N/A 
L125 Random N/A 
L130 Random N/A 
 
Table 3: Sites chosen for TAG codon mutagenesis and the underlying rationale. 
NIS refers to Nodal Interacting Site and AIS refers to Alk4 Interacting Site.  
 
The orthogonal pair, psupT-BpaRS, which site-specifically incorporates Bpa into 
proteins has been shown to be orthogonal in mammalian cells (Hino et al. 2005, 
Valentin-Hansen et al. 2014). With the TAG codon library in hand, we 
proceeded to ask if Bpa could be incorporated at these specific sites of Cripto. 
For this, cells co-transfected with the Cripto-3xFLAG amber plasmid and the 
orthogonal pair for Bpa incorporation were analyzed for full length Cripto-
3xFLAG expression in the presence or absence of Bpa using FLAG 
immunopreciptation and anti-FLAG Western blotting. As shown in Fig. 4.4, we 
observed the expression of Cripto-3xFLAG migrating at the same molecular 
weight as the wild-type Cripto-3xFLAG only when Bpa was added to the 
medium (Fig. 4.5). No such bands were observed in the absence of Bpa, 
indicating that the orthogonal pair is specific for the unnatural amino acid, Bpa 
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and does not incorporate natural amino acids (Fig. 4.5). All 20 TAG codon 
mutants (8 in the EGF domain and 12 in the CFC domain) were amenable for 
Bpa incorporation and no endogenous TAG codon readthrough was observed in 
the absence of Bpa, indicating that Bpa mutagenesis is a viable tool for our 
interaction study. 
 
Figure 4.5: HEK293 c-18 cells were transfected with pcDNA (top panel, lane 1) , 
Cripto-3xFLAG (top panel, lane2) or with the indicated Cripto TAG codon 
plasmid and the psupT-BpaRS orthogonal pair. 4 hours post-transfection, serum-
containing media was replaced with DMEM or DMEM containing 1mM Bpa 
(indicated by – or +). Cells were lysed 36 hours post-transfection, 
immunoprecipitated and Cripto-3xFLAG was eluted and analyzed by FLAG-
HRP Western blotting.  
 
4.5 Optimization of the UV crosslinking apparatus 
It has been speculated previously that the Spectrolinker could offer more 
efficient cross-linking when compared to commercially available UV handheld 
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lamps (Farrell et al. 2005). Since we did not find any experimental evidence for 
this in the literature, we compared the abilities of the UV handheld lamp and the 
Spectrolinker XL-1500 to cross-link GST monomers into their dimeric forms in 
identical conditions. We observed that the Spectrolinker XL-1500 cross-linked 
nearly 100% of the GST-Bpa-FLAG monomers into the dimeric adduct while 
some monomeric GST-Bpa-FLAG remained upon cross-linking by the UV 
handheld lamp (lanes 2 and 4 or lanes 3 and 6). Thus, we conclude that the 





Figure 4.6: HEK293 c-18 cells were transfected with either pcDNA or the GST-
F52Am-FLAG and the psupT-BpaRS orthogonal pair. Bpa media was added 4 
hours post-transfection to all dishes except the pcDNA control. 36 hours post-
transfection, the cells were cross-linked on ice using the indicated apparatus and 
duration. Cells were lysed, GST-FLAG was immunoprecipitated, subjected to 
Western blotting and probed by FLAG-HRP antibodies.  
 
4.6 Cross-linking experiments with Cripto-Bpa-3xFLAG 
Having optimized the UV conditions for efficient cross-linking, we turned our 
attention to our experimental paradigm, the interactions of mouse Cripto. We 
first asked if the wild-type Cripto-3xFLAG can cross-link upon UV excitation to 
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check if there is any non-specific crosslinking mediated by the natural amino 
acids of Cripto-3xFLAG. We observed that even after 30 minutes of 365nm UV 
exposure, the wild-type Cripto-3xFLAG did not form any cross-linked adducts 
(Fig. 4.7). Since there was no evidence of non-specific crosslinking mediated by 
any of the natural amino acids, we next asked if incorporating Bpa site-
specifically into Cripto-3xFLAG would yield crosslinks with the endogenously 
expressed, putative interacting partner Alk4, upon UV exposure. Bpa-mediated 
crosslinking has been touted as a technique that can trap weak and transient 
interactions due its covalent nature (Hino et al. 2005, Abe et al. 2012) and Alk4 
has been shown to be expressed endogenously in HEK293 cells. Furthermore, 
the evidence in the literature suggested that H104 and W107 are critical for Alk4 
binding and we hypothesized that H104Bpa and W107Bpa mutants (and 
proximal mutants) could specifically cross-link to Alk4 (Minchiotti et al. 2001, 
Calvanese et al. 2006). Surprisingly, we found that all the Cripto-Bpa-3xFLAG 
mutants reproducibly yielded crosslinks migrating at approximately 75kD and 
150kD upon UV exposure accompanied by a significant reduction in Cripto-
3xFLAG levels (Fig. 4.8 and 4.9). The cross-linking was found to be UV 
dependent since absence of UV did not yield any cross-links. Moreover, the lack 
of crosslinking of the wild-type Cripto-3xFLAG upon UV exposure strongly 




Figure 4.7: HEK293 c-18 cells were transfected with equal amounts of Cripto-
3xFLAG in 100mm dishes. 36 hours post-transfection, cells were exposed to UV 
as indicated. Cells were lysed, immunoprecipitated with anti-FLAG beads and 
both 3xFLAG peptide elutions and boiling of the beads (post-elution) was 




Figure 4.8: HEK293 c-18 cells were transfected with the orthogonal pair and the 
indicated Cripto amber plasmid to express mutant Cripto-Bpa-3xFLAG protein. 
36 hours post-transfection, cells were exposed to UV as indicated. Cells were 
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lysed, immunoprecipitated with anti-FLAG beads and eluted with 3xFLAG 
peptide.. Samples were subjected to a FLAG-HRP Western blot.  
 
Since Bpa cross-linking is highly specific, the observation that all 20 mutants, 
regardless of the site of Bpa incorporation, yielded identical cross-links, led us to 
speculate that this might be a case of non-specific cross-linking. One of the ways 
in which cross-linking could be non-specific is if the cross-linking occurs co-
translationally while on the ribosome itself. To rule out this possibility, we 
performed a cycloheximide chase assay to see if cross-links persist after 
treatment with cycloheximide. As shown in Fig. 4.9, cross-links for the Cripto-
F78Bpa-3xFLAG and Cripto-W107Bpa-3xFLAG persisted even after 4 hours of 
cycloheximide treatment, Thus, it is unlikely that the cross-links are a co-
translational phenomenon and may in fact reflect interactors trapped after protein 
synthesis.  
   
Figure 4.9: HEK293 c-18 cells were transfected with the indicated amber 
plasmid and the orthogonal pair. Cells were incubated for 36 hours in Bpa 
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medium before addition of cycloheximide. Post-treatment, cells were lysed, 
immunoprecipitated with anti-FLAG beads and analyzed in an anti-FLAG 
Western. 
 
Since the evidence in the literature points to a few specific sites that interact with 
Alk4, we speculated that neither of the 75kD or 150kD adducts could be due to 
cross-linking to endogenously expressed Alk4. In theory though, the 75kD cross-
link could fit well with a 1:1 stoichiometry of Cripto and Alk4. If this is the case, 
we hypothesized that the co-expression of Alk4-HA with the Cripto-Bpa-
3xFLAG mutants would yield similar cross-links in an anti-HA Western. For this, 
we tested 12 Cripto-Bpa-3xFLAG mutants including the surface-exposed 
mutations which we hypothesized to cross-link to Alk4-HA. As shown in Fig. 
4.9, the co-expression of Alk4-HA did not yield any additional crosslinks apart 
from the 75kD and 150kD crosslinks observed even without the expression of 
Alk4-HA. Even the H104Bpa and W107Bpa mutants (or proximal ones) did not 
yield cross-links which could be visualized in an anti-HA western for Alk4. 
Peculiarly, we observed one cross-link, G71Bpa-3xFLAG to Alk4-HA in an 
anti-HA Western but this was not reproducible in our hands. We conclude that 
the C-terminally FLAG tagged Cripto-Bpa mutants do not cross-link to Alk4 and 







Figure 4.10: HEK293 c-18 cells were transfected with the indicated Cripto 
amber plasmid, the orthogonal pair and pAlk4-HA as indicated. Mutant protein 
expression was achieved by the addition of Bpa medium (except for bottom 
panel lane 1, G71Am minus Bpa). Cells were UV-crosslinked 36 hours post-
transfection (as indicated), lysed and immunoprecipitated with anti-FLAG beads. 
FLAG proteins were eluted by 3xFLAG peptide and probed in an anti-FLAG 
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western blot. The membranes were also stripped and re-probed with a rat anti-
HA antibody. Cross-links are indicated by black arrows.  
 
4.7 Bpa mutagenesis and cross-linking of N-ter FLAG-Cripto 
Since the hypothesized CFC domain Cripto-Bpa-3xFLAG mutants did not cross-
link to Alk4, we turned our attention to creating a similar library with an N-
terminally FLAG-tagged Cripto so as not to perturb the C-terminal GPI 
anchorage region. For this, the FLAG tag was inserted after the signal peptide 
(Yan et al. 2002) as depicted in Fig. 4.10. We first verified the activity of FLAG-
Cripto in an ARE-luc activity assay (Fig. 4.12a) and also confirmed its 
membrane localization through our indirect PI-PLC assay (Fig. 4.12b). A FLAG-
Cripto peptide was found to be secreted upon PI-PLC treatment, indicating its 




Figure 4.11: An N-terminally FLAG tagged version of Cripto was generated by 
insertion of the tag after the 17th amino acid of Cripto. The sites chosen for Bpa 






Figure 4.12: (a) HEK293 c-18 cells were transfected with FLAG-Cripto (or 
pcDNA), Nodal (or pcDNA), Fast 2, ARE-luc and Renilla luciferase plasmids in 
24-well dishes in technical triplicates. ARE-luciferase readouts were measured 
24 hours post-transfection and normalized to the Renilla luciferase readouts. The 
readouts are displayed as folds over 2 negative controls (the FLAG-Cripto minus 
in cyan and the Nodal minus control in blue). (b) HEK293 c-18 cells transfected 
with FLAG-Cripto were subjected to PI-PLC treatment 24 hours post-
transfection and the cell lysate (P) and cell free supernatant (S) were probed for 
Cripto in an anti-FLAG Western blot. 
 
Confident that the FLAG-Cripto is both an active and GPI-anchored version, we 
designed a 9-fold TAG codon library by site-directed mutagenesis focusing only 
on the sites hypothesized to interact with Alk4 or Nodal (refer Table 2 and Fig. 
4.10). We then asked if Bpa could be incorporated into these FLAG-Cripto(Am) 
mutants. As shown in Fig. 4.13, the wild-type FLAG-Cripto migrates as 2 bands 
at ~15kD and ~20kD respectively. The 20kD band is speculated to be the mature 
glycosylated Cripto (Yan et al. 2002). We observed that for the FLAG-Cripto 
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TAG mutants of G70, G76, F78, G100, H104, G105, W107 this mature, 
glycosylated version is synthesized only when Bpa was added to the medium 
(Fig. 4.13). The A80 and T106 mutants did not yield the ~20kD mature band or 
the ~15kD precursor version. The lowermost bands in all the lanes correspond to 
the truncated FLAG-Cripto proteins which are immunoprecipitated by the anti-
FLAG beads. Peculiarly, we found a ~15kD band that migrates identically to the 
full-length precursor of the wild-type even when no Bpa was added. Since these 
truncated proteins (barring G70) still retain the 2 sugar modification sites of Asn-
63 (for N-glycan) and Thr-72 (for O-fucose), we hypothesized that the 15kD 
bands seen in the lanes containing only the truncated proteins correspond to the 
glycosylated version of the truncated proteins. To address this, we used an Endo 
H assay used in the Cripto literature to assess the sugar modification status of the 
FLAG-Cripto-Bpa mutants. Endo H is an enzyme that cleaves within the 
chitobiose core of high mannose and some hybrid types of N-linked 
carbohydrates and has been shown to deglycosylate Cripto in the literature 
(Blanchet et al. 2008). Upon Endo H treatment, the wild type migrates a single 
15kD band, indicating its deglycosylated status (data not shown). As shown in 
Fig. 4.14, the mutants migrate as 3 bands, the lower-most one corresponding to 
the truncated protein and the upper 15kD doublet corresponding to the 
deglycosylated Cripto and the precursor. The disappearance of the 20kD mature, 
glycosylated band was observed for all mutants, indicating that they were 
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glycosylated in the first place (compare Fig. 4.13 and 4.14). Moreover, the 
truncated proteins were also reduced from two bands to one band indicating their 
deglycosylation (Fig. 4.14) 
 
 
Figure 4.13: HEK293 c-18 cells were transfected with the wild-type FLAG-
Cripto or pcDNA or the indicated FLAG-Cripto amber plasmid along with the 
orthogonal pair. Cells were incubated for 36 hours post-transfection either in the 
presence or absence of Bpa (as indicated). Cells were lysed, immunoprecipitated 






Figure 4.14: HEK293 c-18 cells were transfected with the indicated amber 
plasmid and the orthogonal pair. Cells were incubated 36 hours post-transfection 
either in the presence or absence of Bpa. Cells were lysed, immunoprecipitated 
with anti-FLAG beads and treated with Endo H. Post-treatment, samples were 
subjected to an anti-FLAG Western blot. For G70, a minus Endo H control was 
included. 
 
Since our FLAG-Cripto Bpa mutants demonstrated evidence for carrying the 
sugar modifications of the wild-type, we wanted to analyze if their activities in 
Nodal signaling could be comparable to that of the wild-type. Furthermore, this 
approach would also allow us to weed out inactive or hyper-active FLAG-
Cripto-Bpa mutants so that only the ones with an activity comparable to that of 
the wild-type can be used in our cross-linking experiments. Due to the large 
amounts of DNA that needs to be transfected for these assays, we adopted a co-
culture assay from Yan et al. 2002, where Nodal could be transfected in a 
separate dish and later pooled with the cells expressing the FLAG-Cripto-Bpa 




Figure 4.15: A schematic for assaying the activity of FLAG-Cripto Bpa mutants. 
Cells expressing Nodal (signaling cells) and the FLAG-Cripto Bpa mutants and 
the luciferase reporter (responding cells) are co-cultured in DMEM containing 
Bpa. Luciferase readouts were measured 36 hours post co-culture. 
 
Considering that protein synthesis using the synthetic biology is not as efficient 
as translation involving purely natural amino acids due to the more frequent 
termination events at the TAG codon, it can be expected that wild-type protein 
expression levels will always be higher than the levels of FLAG-Cripto Bpa 
mutants. Thus, it was imperative that the wild-type be expressed to a level 
approximately equal to that of the FLAG-Cripto Bpa mutants to enable a fair 
comparison of wild-type and mutant activities. As shown in Fig. 4.16, the 
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expression of the FLAG-Cripto Bpa mutants is comparable to the expression the 
FLAG-Cripto wild-type transfected with less than 1 microgram of DNA. 
Considering that we must also account for the presence of the glycosylated 
versions of the truncated proteins, even this comparison to the wild-type is most 
likely an over-estimate. Hence, this co-culture system was not found to be suited 
to measure the activity of FLAG-Cripto Bpa mutants in our hands and an assay 
using secreted versions of FLAG-Cripto Bpa mutants has been proposed as a a 
potential solution in the discussion.  
 
Figure 4.16: HEK293 c-18 cells were transfected with the appropriate plasmids 
depicted in schematic 4.15 and luciferase readouts were measured 36 hours post-
coculture. A separate set of transfections was performed on the same day with 
the same amounts of FLAG-Cripto, amber plasmid and orthogonal pair as the 
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activity assay to compare the protein expressions by FLAG immunoprecipitation 
and anti-FLAG Western blotting. 
 
Nonetheless, since Bpa mutagenesis is not expected to cause any severe 
structural perturbations (Sato et al. 2011), we decided to proceed with cross-
linking experiments. We wanted to ask if any of the CFC domain FLAG-Cripto 
Bpa mutants cross-linked to Act-A and also check if there are any endogenous 
cross-links to proteins such as Alk4. As shown in Fig. 4.17, all 4 CFC domain 
mutants yielded cross-links and the exposure to Act-A did not yield any 
additional cross-links. The cross-links were not seen when the wild-type FLAG-
Cripto was exposed to UV, indicating that they are Bpa-dependent. The identity 
of the cross-links is unknown but a hypothesis regarding their formation is 
proposed in the discussion. 
 
  
Figure 4.17: HEK293 c-18 cells were transfected with FLAG-Cripto or the 
indicated amber plasmid and the orthogonal pair. Cells were incubated for 36 
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hours in Bpa medium before Act-A treatment for 2 hours. Cells were then cross-
linked on ice, lysed, immunoprecipitated with anti-FLAG beads and the peptide 























CHAPTER 5: DISCUSSION 
5.1 Cripto-3xFLAG cannot be the GPI-anchored version 
We first proposed that the widespread use of the Cripto-3xFLAG construct is 
most likely not suited to study the interactions of Cripto in its GPI-anchored state. 
The laws of GPI-anchoring require the C-terminal region after the GPI-
anchorage site be cleaved off (Mayor and Riezmann 2004, Hancock 2004). In 
the case of mouse Cripto, S145 would be the GPI-anchorage site (prediction 
based on Watanabe et al. 2007) and hence, the appearance of full-length Cripto-
3xFLAG in an anti-FLAG Western blot must indicate that GPI anchoring has not 
taken place. Our PI-PLC assays revealed a protein of the expected size in the 
cell-free supernatant of cells expressing untagged Cripto but no such 
extracellular release was observed for Cripto-3xFLAG, indicating that while 
Cripto is GPI-anchored, the same may not be the case with Cripto=3xFLAG.  
Moreover, we did not observe any low MW fragment that could represent the 
cleaved off C-terminal bit after GPI-anchorage in our anti-FLAG western blots. 
It is likely that the inclusion of a 3xFLAG tag itself is a deterrent to the GPI-
anchoring process. In this regard, the mislocalization of a human Cripto S161L 
mutant in the ER could hint at a similar mislocalization defect for the Cripto-
3xFLAG protein (Watanabe et al. 2007). Interestingly, the inclusion of 
hydrophilic tags such as V5 or the 3xFLAG tag at the C-terminus of Cripto 
resulted in lower activity of the protein in luciferase reporter assays when 
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compared to untagged versions (Watanabe et ali. 2007 and our experiments). 
Whether this activity stems from ER-localized Cripto-3xFLAG or from the 
active remnants of the hampered GPI-anchoring process is unclear.  
5.2 The curious case of the identical cross-linking pattern of CriptoBpa-
3xFLAG mutants 
We designed a 20-fold library of CriptoBpa-3xFLAG mutants based primarily 
on the oep phenotypic rescue experiments of Minchiotti et al. (2001). In an 
attempt to investigate an interaction with endogenous Alk4, we identified 2 
cross-links, one at ~75kD and the other at ~ 150kD, appearing upon UV 
exposure of any of the 20 CriptoBpa-3xFLAG mutants. We find this result to be 
peculiar since the crosslinking approach using site-specifically incorporated Bpa 
is known for its resolution (Mohibullah and Hahn 2008, Yu et al 2013, Xiang et 
al 2013, Grunbeck et al 2012, Berg et al. 2014) . However, our results indicate 
that no matter where Bpa is incorporated, be it the EGF or CFC domain, the 
unknown proteins that yield the cross-links are within the short cross-linking 
radius of Bpa. Given the wealth of Bpa crosslinking experiments in the literature, 
our results are unprecedented and perplexing. While it can be speculated that the 
mutants may have crosslinked to some ER chaperone due to folding defects, this 
is unlikely given that 12 mutants immunoprecipitated with Alk4-HA and are 
most likely not suffering from severe structural perturbations. 
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Although the identity of these interacting partners is unknown, we propose that 
they may not be due to Alk4 for 2 reasons. Firstly, all previous evidence for the 
Cripto-Alk4 interaction pointed towards a role for the CFC domain and 
especially the surface-exposed H104 and W107 residues as the points of contact. 
Hence, it is unlikely that our ~75kD cross-link is Alk4, given that the cross-link 
is observed for the EGF-domain Bpa mutants too. Secondly, if any of the 2 
cross-links did belong to Alk4, the over-expression of Alk4-HA should yield an 
identical result in the anti-HA Western and we show that this is not the case. One 
mutant, Cripto G71Bpa-3xFLAG yielded a cross-link revealed in both the anti-
FLAG and anti-HA Western, but this result was not reproducible in our hands. 
Our biochemistry also revealed that 12 mutants immunoprecipitated Alk4-HA 
but did not cross-link with it. Work from Sato et al. (2011) revealed that the 
incorporation of Bpa may not lead to structural perturbations and hence it is 
likely that our CriptoBpa-3xFLAG mutants are correctly folded and hence retain 
a biochemical interaction with Alk4-HA. The observation that CriptoBpa-
3xFLAG mutants immunoprecipitate with Alk4 but do not cross-link with it 
might appear paradoxical but the differences between the conventional 
immunoprecipitation and Bpa-mediated cross-linking could help explain the 
discrepancy.First, immunoprecipitation is a post-lysis interaction technique and 
is more susceptible to picking up non-specific interactions. Bpa-mediated cross-
linking is done on live cells and is a more stringent approach to investigate 
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protein-protein interactions. Given the amount of evidence for the Cripto-Alk4 
interaction in the literature, it is highly unlikely that the Cripto-Alk4 interaction 
is a non-specific one. Second, if we assume that the Cripto-Alk4 interaction is 
specific, then the question arises as to why none of the CriptoBpa-3xFLAG 
mutants, especially H104Bpa and W107Bpa did not cross-link to Alk4-HA. An 
answer to this might lie in the structural investigations of a gankyrin-R85Bpa – 
S6C proteasomal domain co-crystal (Sato et al. 2011). An investigation into the 
geometric relationship between the carbonyl group of Bpa and the reactive C-H 
group on the interacting partner revealed that there is a narrow window of 
distance and angle between the 2 groups that facilitates covalent cross-linking. In 
the absence of a Cripto-Alk4 co-crystal, the presence of such structural 
constraints could possibly prevent covalent cross-linking by Bpa.       
5.3 Bpa mutagenesis of FLAG-Cripto 
We successfully incorporated Bpa into 7 sites of FLAG-Cripto. Considering our 
PI-PLC assay which revealed that FLAG-Cripto is GPI-anchored, it is highly 
likely that our FLAG-CriptoBpa mutants are GPI-anchored too since the native 
C-terminal region was preserved. Endo H assays revealed that these mutants 
carried sugar modifications as is expected of wild-type Cripto. Our activity 
assays were inconclusive since in our hands, the activity of the wild-type FLAG-
Cripto was not high enough to make a reasonable comparison. As an alternative, 
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a biochemical activity assay such as Phospho-Smad2 Western blotting may 
provide a more definitive answer to the activity question. Cripto has been shown 
to signal as a secreted co-ligand with Nodal and it may even be possible to purify 
these FLAG-CriptoBpa mutants as secreted proteins by PI-PLC treatments and 
use them for activity assays through the ARE-reporter assay.  
Our cross-linking experiments revealed that the CFC domain mutants 
reproducibly yielded endogenous cross-links at the same MW whose identity is 
unknown. We propose a hypothesis based on one previous study which revealed 
that GPI-anchored proteins can cross-link to themselves into high MW oligomers 
due to tight packing in lipid rafts (Friedrichson and Kurzchalia 2008). The cross-
linker used was BS3 which has a longer cross-linking distance than Bpa and 
hence whether the high MW cross-links observed in our hands is due to Cripto-
Cripto interaction needs to be investigated using cholesterol-depleted cells. We 
also propose that the cross-linking experiments be performed with the secreted 
ligand versions to overcome the hypothesized limitation. If our hypothesis is true, 
it could have far reaching implications when it comes to the study of interactions 





CHAPTER 6: CONCLUSIONS AND FUTURE DIRECTIONS 
The precise geometry of the Nodal signaling complex and the direct, bona fide 
interactions of mouse Cripto was an open problem at the time of this thesis. We 
addressed this using a recently established synthetic biology approach that site-
specifically incroporates the cross-linking unnatural amino acid, Bpa, into 
proteins in mammalian cell platform. We successfully incorporated Bpa into 20 
sites of Cripto-3FLAG and 7 sites of FLAG-Cripto for the first time in the 
literature. All 20 Cripto-Bpa-3xFLAG mutants revealed cross-links to 
endogenous proteins at MWs of ~75kD and ~150kD, a peculiar observation 
given the resolving power of Bpa crosslinking. Nonetheless, it would be 
interesting to identify the proteins in these cross-links through mass spectrometry. 
No additional cross-links to Alk4-HA were observed for 12 of these mutants, 
although evidence for co-immunoprecipitation was seen. Our cross-linking 
experiments with the FLAG-Cripto Bpa mutants also revealed endogenous 
cross-links which we hypothesize to be arising due to tight packing of GPI-
anchored proteins in the lipid rafts. We propose cross-linking experiments with 
the secreted ligand versions of FLAG-Cripto-Bpa to circumvent the above 
problem. Moreover, the interactions of soluble Cripto have never been 
investigated in the literature and our proposed approach could yield novel 
insights into the interactions of soluble mouse Cripto. In terms of the technique 
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of UV cross-linking, we demonstarted that the Spectrolinker is a more efficient 
cross-linking apparatus than the UV handheld lamp and could have serious 
implications for interactors where the cross-linking efficiency is quite low. 
Finally, we raise concerns about the use of C-terminally tagged GPI-anchored 
proteins such as the Cripto-3xFLAG. Based on GPI-anchoring theory and a 
simple PI-PLC assay, we propose that Cripto-3xFLAG is not the GPI-anchored 
form and hence argue strongly against its use as a template to study interactions, 
especially with ligands.   
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